Elder Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Jun ' 14	Jun ' 13	Mar ' 12	Mar ' 11	Mar ' 10

Profit before tax

-362.19

115.70

103.51

89.07

64.68

Net cashflow-operating activity

1,153.39

-26.84

19.48

51.79

8.93

Net cash used in investing activity

-14.99

-48.17

-145.18

-52.32

-137.00

Netcash used in fin. activity

-687.85

33.51

3.36

174.90

141.59

Net inc/dec in cash and equivlnt

450.55

-41.50

-122.34

174.36

13.52

Cash and equivalnt begin of year

87.83

129.34

251.67

77.31

63.79

Cash and equivalnt end of year

538.39

87.83

129.34

251.67

77.31